Kane Biotech Inc. announced the appointment of Gordon Guay, Ph.D., a member of Kane's Scientific Advisory Board (SAB), to Chief Scientific Officer of the Company. Dr. Guay's depth of expertise in orchestrating and engineering the scientific advantages of many popular consumer products found on store shelves carries significant value as Kane Biotech looks to improve the implementation of its anti-biofilm technologies further into the industrial, animal and human health arenas. Gordon has over twenty-five years of experience in R&D and new product development. He has worked as a Research Fellow at Proctor and Gamble, serving as the lead scientist within a range of different P&G business units including: Oral-B, Gillette, Olay, Right Guard, CoverGirl, Max Factor and Duracell. Gordon has received over 11 international awards for new products developed during his tenure at P&G. Prior to P&G, Gordon was the Director of Research at Catalytic Antibodies Inc.